Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group. McGuigan C, Craner M, Guadagno J, Kapoor R, Mazibrada G, Molyneux P, Nicholas R, Palace J, Pearson OR, Rog D, et al. J Neurol Neurosurg Psychiatry. 2015 Oct 22. PMID: 26492930. Abstract CommentRecommendBookmarkWatch